Management described seeking an amendment to the VERSATILE-003 protocol to elevate progression-free survival (PFS) as a surrogate primary endpoint, in addition to maintaining median overall survival ...

SAN ANTONIO--(BUSINESS WIRE)--Hera Biotech is pleased to report the interim results for its proof-of-concept multi-center clinical trial of the MetriDx™ endometriosis diagnostic test. Per protocol ...

Puma Biotechnology Announces Agreement with FDA on Special Protocol Assessment for Phase III Trial of PB272 (Neratinib) in HER2-Positive Metastatic Breast Cancer Patients Pursuant to the SPA and SA, ...

I believe that a good speculative biotech to go over for the "Exclusive BAC Subscribers Article" would be Moleculin Biotech (MBRX). The reason why I want to go over this biotech next is because it ...

VERSATILE-003 will evaluate PDS0101 in combination with KEYTRUDA ® in recurrent or metastatic HPV16-positive head and neck cancer PDS Biotech anticipates initiating the VERSATILE-003 trial in the ...

Bio Protocol enables researchers and patients to launch BioAgents - autonomous AI co-scientists that generate hypotheses, fund experiments and monetize biotech discoveries outside traditional pharma.